|Bid||0.00 x 1000|
|Ask||0.00 x 40000|
|Day's Range||127.92 - 127.97|
|52 Week Range||4.80 - 127.97|
|PE Ratio (TTM)||22.92|
|Earnings Date||Jun 26, 2018 - Jul 2, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||127.00|
Germany's Bayer will wrap up the $63 billion takeover of Monsanto on Thursday and also retire the U.S. seeds maker's 117 year-old name. Thuy Ong reports
Hundreds of lawsuits against Monsanto Co by cancer survivors or families of those who died can proceed to trial, a federal judge ruled on Tuesday, finding there was sufficient evidence for a jury to hear the cases that blame the company's glyphosate-containing weed-killer for the disease. The decision by U.S. District Judge Vince Chhabria in San Francisco followed years of litigation and weeks of hearings about the controversial science surrounding the safety of the chemical glyphosate, the key ingredient in Monsanto's top-selling weed-killer. Monsanto is now a unit of Bayer AG , following a $62.5 billion takeover of the U.S. seed major which closed in June.
Monsanto has long worked to “bully scientists” and suppress evidence of the cancer risks of its popular weedkiller, a lawyer argued on Monday in a landmark lawsuit against the global chemical corporation. “Monsanto has specifically gone out of its way to bully ... and to fight independent researchers,” said the attorney Brent Wisner, who presented internal Monsanto emails that he said showed how the agrochemical company rejected critical research and expert warnings over the years while pursuing and helping to write favorable analyses of their products. Wisner, who spoke inside a crowded San Francisco courtroom, is representing DeWayne Johnson, known also as Lee, a California man whose cancer has spread through his body.
German conglomerate Bayer on Thursday closed its $63 billion merger with St. Louis-based agribusiness giant Monsanto and plans to drop the U.S. company's name.
Jim Cramer muses on what Twitter's entry into the S&P 500 index means for the future of the stock market.
Cramer highlights the differences between Twitter and Monsanto, the company that the social media stock will be replacing in the index. On Tuesday, that came to the fore when Dow Jones Indices announced that the stock of Twitter TWTR would replace agrochemical play Monsanto MON in the S&P 500 index.
Twitter Inc. is slated to join the S&P 500 before trading opens on Thursday, according to S&P Dow Jones Indices, as the social-media platform replaces Monsanto Co. on the widely watched index.
Twitter (ticker: TWTR) will ascend to the S&P 500, replacing Monsanto (MON), the S&P Dow Jones Indices said late Monday. Netflix (NFLX) will replace Monsanto Company in the S&P 100. The moves, effective ...
Twitter jumped 5 percent in extended trading on Monday, after the Dow Jones announced the social media company would replace Monsanto in the S&P 500.
Twitter jumped 5 percent in extended trading on Monday, after the Dow Jones announced the social media company would replace Monsanto in the S&P 500. The changes will go into effect prior to market open on Thursday, June 7, when German pharmaceutical and life sciences company Bayer wraps up its $63 billion takeover of seed-maker Monsanto.
Nvidia, Amazon, Monsanto and MGM are the companies to watch.
The Monsanto company name, which has become synonymous with genetically modified food and as a longstanding target of environmental activists, will disappear after the completion of its $63bn (£47bn) sale to the German company Bayer on Thursday. Bayer, a pharmaceuticals and chemicals giant, said on Monday it would immediately retire the 117-year-old Monsanto brand name.
Germany's Bayer (BAYGn.DE) will wrap up the $63 billion takeover of Monsanto (NYSE:MON - News) on Thursday and also retire the U.S. seeds maker's 117 year-old name. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement on Monday. "Bayer will remain the company name.
Bayer said it will raise €6 billion in cash from a share sale to finance its $66 billion takeover of Monsanto.
Bayer (BAYGn.DE) launched a 6 billion euros ($7 billion) rights issue on Sunday, a cornerstone of the financing package for its planned $62.5 billion takeover of seeds maker Monsanto (:MON - News). Bayer last week won U.S. approval for the Monsanto takeover, clearing a major hurdle for a deal that will create by far the largest seeds and pesticides maker. The cash call is smaller than initially envisaged by Bayer because Monsanto reduced its debt while the antitrust review dragged on.
Bayer's planned $62.5 billion takeover of seeds maker Monsanto is set to close on Thursday, Germany's Frankfurter Allgemeine Sonntags Zeitung reported. A Bayer spokesman declined to comment on the Sunday newspaper report. Bayer last week won U.S. approval for the Monsanto takeover after months of delays in a drawn-out review, clearing a major hurdle for a deal that will create by far the largest seeds and pesticides maker.
Bayer's planned $62.5 billion takeover of seeds maker Monsanto is set to close on Thursday, Germany's Frankfurter Allgemeine Sonntags Zeitung reported. A Bayer spokesman declined to comment on the Sunday ...
The first-quarter 13F filings indicate that institutional investors own 70.9% of DowDuPont’s (DWDP) outstanding shares. A total of 1,957 institutions hold DowDuPont. Among the institutions, 825 increased their positions on DowDuPont, 908 reduced their positions, and 224 maintained their positions. Although more institutions sold DowDuPont, more shares were bought by institutions than the number of shares sold.
In comparison, Monsanto (MON), LyondellBasell (LYB), and Eastman Chemical (EMN) have gained 9.1%, 1.0%, and 12.5%, respectively. There have been volatile market conditions, prevailing geopolitical tensions, and the impact of proposed tariffs by China on US exports. DowDuPont is one of the companies that would be impacted negatively by the tariffs.
The latest short interest data as of May 15 showed that DowDuPont’s (DWDP) short interest has risen sequentially on the back of its first-quarter earnings. According to the data, its short interest as a percentage of outstanding shares was 0.90%. For the same period, DWDP stock rose from $64.92 to $67.15.
The Justice Department granted antitrust approval on Tuesday for Bayer's (BAYRY) proposed acquisition of Monsanto (MON), after requiring the German giant to divest roughly $9 billion worth of assets and businesses. So let's dive into a quick overview of everything investors need to know about the deal.
On May 23, Dow Chemical, which is now a merged entity of DowDuPont (DWDP), expanded its presence in Canada with a new regional sales center in Toronto. The new center was inaugurated on May 24 in the presence of Canadian government officials and Dow’s leadership. Dow sees a growth opportunity in the expanding Canadian economy.
On May 24, International Flavors and Fragrances announced that it would partner with Amkiri—an Israeli-based startup that was founded in 2014. International Flavors and Fragrances is always focused on innovation. Amkiri has patented Visual Fragrance, which could be a sensational product in body art business.
FRANKFURT/WASHINGTON (Reuters) - Bayer (BAYGn.DE) won U.S. approval for its planned takeover of Monsanto (:MON - News) after agreeing to sell about $9 billion in assets, clearing a major hurdle for the $62.5 billion deal that will create by far the largest seeds and pesticides maker. A Bayer spokesman said the planned sale of businesses with 2.2 billion euros ($2.54 billion) in sales to BASF already agreed to address antitrust concerns, mainly in Europe, were not materially different from the DoJ's demands. "Receipt of the DOJ's approval brings us close to our goal of creating a leading company in agriculture," Bayer CEO Werner Baumann said in a statement.
WASHINGTON—The Justice Department granted antitrust approval Tuesday to Bayer AG’s planned acquisition of Monsanto Co., after requiring the German company to sell off about $9 billion in assets in order to preserve competition. The department said the Bayer assets, which are being sold to chemicals rival BASF SE, amount to the largest divestiture ever in a U.S. merger-approval settlement. The acquisition was originally valued at more than $60 billion.